Compass Therapeutics (CMPX) Financial Statements

Price: $1.75
Market Cap: $241.99M
Avg Volume: 1.65M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.187
52W Range: $0.765-4.08
Website: Compass Therapeutics

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Compass Therapeutics.


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$3.00M$3.00M$2.40M$2.40M$1.80M$1.80M$1.20M$1.20M$600.00K$600.00K$0.00$0.00Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Operating Expenses
Operating Income
Operating Expenses & Income$60.00M$60.00M$30.00M$30.00M$0.00$0.00-$30.00M-$30.00M-$60.00M-$60.00M-$90.00M-$90.00MJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020 March 31, 2019
Revenue $- $- $- $- $- $-
Cost of Revenue $1.89M $1.90M $1.62M $2.40M $2.12M $1.92M
Gross Profit $-1.89M $-1.90M $-1.62M $-2.40M $-2.12M $-1.92M
Gross Profit Ratio - - - - - -
Research and Development Expenses $37.42M $30.00M $20.34M $14.90M $22.45M $27.09M
General and Administrative Expenses $12.24M $11.66M $10.93M $12.91M $11.60M $11.22M
Selling and Marketing Expenses $11.04M $- $- $- $- $-
Selling General and Administrative Expenses $11.05M $11.66M $10.93M $12.91M $11.60M $11.22M
Other Expenses $- $- $50.62M $- $- $-
Operating Expenses $48.47M $41.66M $31.26M $27.81M $34.05M $38.31M
Cost and Expenses $50.36M $41.66M $31.26M $27.81M $34.05M $38.31M
Interest Income $- $2.36M $29.00K $88.00K $743.00K $663.00K
Interest Expense $- $2.36M $370.00K $908.00K $1.23M $767.00K
Depreciation and Amortization $1.89M $1.90M $1.62M $2.40M $2.12M $1.92M
EBITDA $-48.47M $-37.39M $-29.61M $-25.32M $-31.19M $-35.73M
EBITDA Ratio - - - - - -
Operating Income $-50.36M $-41.66M $-81.88M $-27.81M $-34.05M $-38.31M
Operating Income Ratio - - - - - -
Total Other Income Expenses Net $7.87M $2.43M $-299.00K $-1.66M $-601.00K $233.00K
Income Before Tax $-42.49M $-39.23M $-82.18M $-29.47M $-34.65M $-38.18M
Income Before Tax Ratio - - - - - -
Income Tax Expense $- $-2.43M $370.00K $32.00K $91.00K $103.00K
Net Income $-42.49M $-36.80M $-82.55M $-29.50M $-34.74M $-38.29M
Net Income Ratio - - - - - -
EPS $-0.33 $-0.35 $-1.31 $-0.96 $-0.67 $-0.73
EPS Diluted $-0.33 $-0.35 $-1.31 $-0.96 $-0.67 $-0.73
Weighted Average Shares Outstanding 127.03M 105.19M 62.87M 30.78M 52.11M 52.11M
Weighted Average Shares Outstanding Diluted 127.03M 105.19M 62.87M 30.78M 52.11M 52.11M
SEC Filing Source Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$200.00M$200.00M$150.00M$150.00M$100.00M$100.00M$50.00M$50.00M$0.00$0.00Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Equity$240.00M$240.00M$160.00M$160.00M$80.00M$80.00M$0.00$0.00-$80.00M-$80.00M-$160.00M-$160.00MJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020 March 31, 2019
Cash and Cash Equivalents $24.23M $34.95M $144.51M $47.08M $25.30M $57.51M
Short Term Investments $128.23M $151.66M $- $- $- $-
Cash and Short Term Investments $152.46M $186.61M $144.51M $47.08M $25.30M $57.51M
Net Receivables $- $- $- $- $- $-
Inventory $- $- $- $- $- $-
Other Current Assets $1.42M $8.18M $2.59M $3.13M $935.00K $1.37M
Total Current Assets $153.88M $194.79M $147.10M $50.20M $26.24M $58.88M
Property Plant Equipment Net $2.67M $4.53M $6.33M $1.13M $3.75M $5.37M
Goodwill $- $- $- $- $- $-
Intangible Assets $- $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $- $-
Long Term Investments $- $- $- $263.00K $263.00K $262.00K
Tax Assets $- $- $- $- $- $-
Other Non-Current Assets $320.00K $320.00K $320.00K $320.00K $129.00K $115.00K
Total Non-Current Assets $2.99M $4.85M $6.65M $1.71M $4.14M $5.74M
Other Assets $- $- $-0 $- $- $-
Total Assets $156.88M $199.65M $153.76M $51.91M $30.38M $64.62M
Account Payables $4.09M $3.38M $867.00K $1.06M $629.00K $1.73M
Short Term Debt $1.20M $1.10M $989.00K $7.47M $5.58M $3.69M
Tax Payables $- $- $- $- $555.00K $519.00K
Deferred Revenue $- $- $- $- $3.12M $519.00K
Other Current Liabilities $-1.58M $8.31M $7.91M $510.00K $-690.00K $279.00K
Total Current Liabilities $7.80M $16.17M $10.63M $10.10M $9.82M $8.46M
Long Term Debt $536.00K $1.84M $3.05M $1.87M $9.29M $11.06M
Deferred Revenue Non-Current $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $- $-
Other Non-Current Liabilities $-1 $- $- $- $129.87M $129.87M
Total Non-Current Liabilities $536.00K $1.84M $3.05M $1.87M $139.16M $140.93M
Other Liabilities $1 $- $- $- $- $-
Total Liabilities $8.34M $18.01M $13.68M $11.97M $148.98M $149.40M
Preferred Stock $- $- $- $- $129.87K $129.87M
Common Stock $13.00K $13.00K $10.00K $5.00K $3.31M $2.39M
Retained Earnings $-315.31M $-272.81M $-233.59M $-151.41M $-121.91M $-87.16M
Accumulated Other Comprehensive Income Loss $37.00K $-302.00K $0 $-0 $-3.43M $-4.10M
Other Total Stockholders Equity $463.80M $454.74M $373.66M $191.35M $3.31M $-125.77M
Total Stockholders Equity $148.54M $181.64M $140.08M $39.95M $-118.60M $-84.77M
Total Equity $148.54M $181.64M $140.08M $39.95M $-118.60M $-84.77M
Total Liabilities and Stockholders Equity $156.88M $199.65M $153.76M $51.91M $30.38M $64.62M
Minority Interest $- $- $- $- $- $-
Total Liabilities and Total Equity $156.88M $199.65M $153.76M $51.91M $30.38M $64.62M
Total Investments $128.23M $151.66M $- $263.00K $263.00K $262.00K
Total Debt $1.73M $2.94M $4.04M $9.33M $14.87M $14.75M
Net Debt $-22.50M $-32.01M $-140.48M $-37.74M $-10.43M $-42.76M

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$40.00M$40.00M$0.00$0.00-$40.00M-$40.00M-$80.00M-$80.00M-$120.00M-$120.00M-$160.00M-$160.00MJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Financing Cash Flow$120.00M$120.00M$90.00M$90.00M$60.00M$60.00M$30.00M$30.00M$0.00$0.00Jul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020 March 31, 2019
Net Income $-42.49M $-39.23M $-82.18M $-29.50M $-34.74M $-38.29M
Depreciation and Amortization $1.89M $1.90M $1.62M $2.40M $2.12M $1.92M
Deferred Income Tax $- $- $50.58M $837.00K $109.00K $-261.00K
Stock Based Compensation $6.12M $5.33M $4.03M $4.02M $915.00K $656.00K
Change in Working Capital $-2.91M $-1.26M $6.25M $-3.60M $-257.00K $2.17M
Accounts Receivables $- $- $- $- $- $-
Inventory $- $- $- $- $- $-
Accounts Payables $708.00K $2.52M $-194.00K $432.00K $-1.10M $992.00K
Other Working Capital $-3.62M $-3.78M $6.44M $-4.03M $844.00K $1.18M
Other Non Cash Items $5.97M $-871.00K $41.00K $-960.00K $116.00K $121.00K
Net Cash Provided by Operating Activities $-40.62M $-34.12M $-19.67M $-26.80M $-31.74M $-33.68M
Investments in Property Plant and Equipment $-30.00K $-212.00K $-1.57M $-106.00K $-466.00K $-2.02M
Acquisitions Net $- $176.00K $116.00K $144.00K $- $-
Purchases of Investments $-155.42M $-200.12M $- $- $- $-
Sales Maturities of Investments $182.41M $48.95M $- $- $- $-
Other Investing Activities $27.00K $-150.99K $-318.00K $144 $- $-
Net Cash Used for Investing Activities $26.96M $-151.20M $-1.77M $38.00K $-466.00K $-2.02M
Debt Repayment $- $- $- $- $- $-
Common Stock Issued $3.09M $76.24M $128.27M $60.48M $- $49.08M
Common Stock Repurchased $-159 $- $- $- $- $-
Dividends Paid $- $- $- $- $- $-
Other Financing Activities $-159.00K $-480.00K $-281.00K $-6.32M $37.62K $64.03M
Net Cash Used Provided by Financing Activities $2.94M $75.76M $118.61M $48.54M $37.62K $64.03M
Effect of Forex Changes on Cash $- $- $- $- $-37.62K $-
Net Change in Cash $-10.72M $-109.57M $97.17M $21.77M $-32.21M $28.33M
Cash at End of Period $24.23M $34.95M $144.51M $47.34M $25.57M $57.77M
Cash at Beginning of Period $34.95M $144.51M $47.34M $25.57M $57.77M $29.44M
Operating Cash Flow $-40.62M $-34.12M $-19.67M $-26.80M $-31.74M $-33.68M
Capital Expenditure $-30.00K $-212.00K $-1.57M $-106.00K $-466.00K $-2.02M
Free Cash Flow $-40.65M $-34.34M $-21.23M $-26.91M $-32.21M $-35.70M